| Particulars |
| Company Name |
Glenmark Pharmaceuticals Ltd |
Year End |
202503 |
| Full Year |
| Equity (Rs Cr.) |
28.22 |
B.V. Rs |
868.30 |
| Sales Rs Cr. |
9,226.41 |
NP Rs Cr. |
1,744.33 |
| NP Var% |
22.00 |
Div% |
250.00 |
| CPS Rs |
69.60 |
EPS Rs |
61.80 |
| Traded Value(Rs Lakhs) |
198.26 |
52 Week High |
2,286.00 |
| 52 Week Low |
1,275.00 |
Price BSE |
2,085.00 |
| Price NSE |
2,085.00 |
Market Capital(Rs Cr.) |
58,827.58 |
| P/C Ratio |
30.00 |
P/E Ratio |
33.70 |
| Price Vs.BV |
2.40 |
|
| Latest Quarter |
| Year End |
202506 |
Sales Rs Cr. |
2,178.90 |
| NP Rs Cr. |
596.30 |
NP Var % |
31.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
8,273.06 |
| OPM |
26.59 |
NP |
1,895.02 |
| NP Var% |
15.83 |
EPS |
66.40 |
| PE |
31.39 |
|
|